InvestorsHub Logo
Followers 21
Posts 3555
Boards Moderated 0
Alias Born 12/18/2019

Re: hoffmann6383 post# 507690

Tuesday, 08/23/2022 10:28:16 PM

Tuesday, August 23, 2022 10:28:16 PM

Post# of 695351
Read the release again. It says MHRA required an approved pediatric trial plan as part of an adult application. It says the pediatric trial can be deferred .

Says nothing about any adult trial deferral. If the FDA rejects the P3 trial data and requires another P3 trial in order to consider an approval application, it would be a financial disaster for NWBO. Another decade long trial sucking cash out of shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News